Stay updated on Dasiglucagon in Congenital Hyperinsulinism Children Clinical Trial
Sign up to get notified when there's something new on the Dasiglucagon in Congenital Hyperinsulinism Children Clinical Trial page.

Latest updates to the Dasiglucagon in Congenital Hyperinsulinism Children Clinical Trial page
- Check3 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check10 days agoChange DetectedA site-wide NIH banner announces that federal agencies are transitioning to the term “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference0.7%

- Check17 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check24 days agoChange DetectedThe site revision label in the footer changed from v3.7.0 to v3.7.1. The study record content remains unchanged.SummaryDifference0.1%

- Check45 days agoChange DetectedThe record history now includes a new revision entry labeled v3.7.0, and the previous revision v3.6.6 was removed from the visible list, reflecting an update to the study’s historical record.SummaryDifference0.1%

- Check66 days agoChange DetectedA new revision entry, v3.6.6, was added to the page history, replacing the previous v3.6.5, indicating an update to the page's version.SummaryDifference0.1%

Stay in the know with updates to Dasiglucagon in Congenital Hyperinsulinism Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dasiglucagon in Congenital Hyperinsulinism Children Clinical Trial page.